Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-29
DOI
10.1038/s41467-021-26479-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers
- (2021) Sheila F Lumley et al. CLINICAL INFECTIOUS DISEASES
- Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection
- (2021) Jennifer S. Chen et al. JOURNAL OF VIROLOGY
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
- (2021) Kate M. Bubar et al. SCIENCE
- Anomalous collapses of Nares Strait ice arches leads to enhanced export of Arctic sea ice
- (2021) G. W. K. Moore et al. Nature Communications
- Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
- (2021) Piyada Supasa et al. CELL
- The antigenic anatomy of SARS-CoV-2 receptor binding domain
- (2021) Wanwisa Dejnirattisai et al. CELL
- Estimated half-life of SARS-CoV-2 anti-spike antibodies more than double the half-life of anti-nucleocapsid antibodies in healthcare workers
- (2021) Jan Van Elslande et al. CLINICAL INFECTIOUS DISEASES
- Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
- (2021) Jan Van Elslande et al. JOURNAL OF CLINICAL VIROLOGY
- Sex differences in the evolution of neutralizing antibodies to SARS-CoV-2
- (2021) Ludivine Grzelak et al. JOURNAL OF INFECTIOUS DISEASES
- Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
- (2021) Kanika Vanshylla et al. Cell Host & Microbe
- Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
- (2021) Nicholas A Kennedy et al. GUT
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
- (2021) Victoria Jane Hall et al. LANCET
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
- (2021) Emma Pritchard et al. NATURE MEDICINE
- Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time
- (2021) A Sarah Walker et al. eLife
- Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
- (2021) Wan Ni Chia et al. Lancet Microbe
- A comparison study of SARS‐CoV‐2 IgG antibody between male and female COVID‐19 patients: A possible reason underlying different outcome between sex
- (2020) Fanfan Zeng et al. JOURNAL OF MEDICAL VIROLOGY
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- (2020) Kelvin Kai-Wang To et al. LANCET INFECTIOUS DISEASES
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
- (2020) Jiandong Huo et al. Cell Host & Microbe
- Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection
- (2020) Kai Wang et al. CLINICAL INFECTIOUS DISEASES
- Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections
- (2020) Ger Rijkers et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
- (2020) F. Javier Ibarrondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study
- (2020) Rita Christiane Baron et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions
- (2020) Madeleine J. Bunders et al. IMMUNITY
- Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee
- (2020) Manish M. Patel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody response to SARS-CoV-2 in people living with HIV
- (2020) Shinya Yamamoto et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
- (2020) Mark Ainsworth et al. LANCET INFECTIOUS DISEASES
- Sex differences in immune responses that underlie COVID-19 disease outcomes
- (2020) Takehiro Takahashi et al. NATURE
- Understanding protection from SARS-CoV-2 by studying reinfection
- (2020) Julie Overbaugh NATURE MEDICINE
- Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders
- (2020) Emelie Marklund et al. PLoS One
- Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies
- (2020) Albrecht Betrains et al. BRITISH JOURNAL OF HAEMATOLOGY
- COVID-19-neutralizing antibodies predict disease severity and survival
- (2020) Wilfredo F. Garcia-Beltran et al. CELL
- High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris
- (2020) François Anna et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Convalescent plasma therapy for the treatment of patients with COVID ‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels
- (2020) Heli Harvala et al. TRANSFUSION MEDICINE
- Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
- (2020) Koen B Pouwels et al. Lancet Public Health
- Heterogeneity and longevity of antibody memory to viruses and vaccines
- (2018) Alice Antia et al. PLOS BIOLOGY
- Joint latent class models for longitudinal and time-to-event data: A review
- (2012) Cécile Proust-Lima et al. STATISTICAL METHODS IN MEDICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now